Locations:
Abu Dhabi|Canada|Florida|London|Nevada|Ohio|
Gray gradientGray gradient
Cleveland Clinic icon
Consult QD logo
Search IconSearch

Heart, Vascular and Thoracic

Imaging showing ischemic mitral regurgitation (large image) and the myocardial infarct.

Consider Both MR Severity and Infarct Size to Assess Risk in Ischemic Cardiomyopathy

Cardiac magnetic resonance can quantify interaction of size and severity

19-HRT-6548-CIED-650×450

Patients Know Less Than They Think About Their CIEDs, Survey Finds

Results also show eagerness to learn more

lipoprotein(a) particle

Elevated Lipoprotein(a): Is a Long-Sought Treatment Finally on the Way?

New phase 2 data boost hopes for phase 3 Lp(a) HORIZON trial

low-density lipoprotein (LDL) particles

Two Reasons Why LDL Cholesterol Management Isn’t as Settled as You May Think

Intermittent statin dosing & bempedoic acid refresh the mix of options

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

small vessel pathology in systemic sclerosis

Cardiovascular Complications of Systemic Sclerosis: What to Look For

Cardiac manifestations of this autoimmune disorder can be hidden but deadly

giant platelets
December 11, 2019/Cancer

An Improbable Aortic Surgery in the Setting of Giant Platelet Disorder

Multidisciplinary collaboration enables first such operation in a patient with MYH9 mutation

gut microbiome

$12 Million NIH Grant Aims to Drive Deeper Discovery of Heart Health/Gut Microbe Links

Hazen group to pursue research programs in atherosclerosis, thrombosis, obesity

19-HRT-6507 Vitals-650×450

Check Out These Outcomes in Adult Cardiac Surgery, CABG and Vascular Disease (Infographic)

A sampling of outcome and volume data from our Heart & Vascular Institute

CT angiogram of the heart

Final EXCEL Results on Revascularization Choice in Left Main Disease: Interpret With Caution

Expert analysis argues that study design may have disadvantaged CABG

19-HRT-5575-bioresorbable-scaffold-650×450

After ABSORB III: What’s Next in Bioresorbable Scaffolds?

With 5-year results now in, a lead investigator looks ahead

BackPage 50 of 62Next

Advertisement

Ad